Urotherapy

Urotherapy is considered the cornerstone of conservative management for bladder and bowel dysfunction and is typically recommended before pharmacological or surgical interventions. It overlaps with behavioral therapy and pelvic floor physical therapy but is distinguished by its structured focus on bladder and bowel physiology, toileting behavior, and coordinated management of urinary and bowel symptoms.^[10][11] Pharmacological treatments, such as anticholinergic medications for overactive bladder or laxatives for constipation, are often introduced as adjuncts when symptoms persist despite adequate urotherapy.^[12] Clinical guidelines emphasize that medication is generally more effective when combined with ongoing urotherapy rather than used as a standalone intervention.^[13][14]

In refractory cases, additional treatments including neuromodulation, botulinum toxin injections, or surgical interventions may be considered following comprehensive urotherapy and appropriate diagnostic evaluation. Most pediatric continence guidelines recommend that conservative urotherapy be attempted and optimized prior to escalation to invasive therapies.^[15][16]

Multiple systematic reviews and clinical guidelines support urotherapy as an effective first line intervention for pediatric BBD. Studies report improvements in daytime incontinence, nighttime wetting, constipation severity, and uroflowmetry patterns after structured urotherapy programs. Adherence to the program, including maintaining voiding schedules and addressing constipation, is a key factor in treatment success. Long term follow up suggests that early intervention may reduce the risk of recurrent urinary tract infections and secondary psychological impacts associated with chronic continence problems.^{[17][18][19][20][21]}